Showing results (11-20 of 861) with videos related to
Sort By:
Pageof 87
BMC Medicine|June 19, 2019
Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial dataFrancesca Bovis, Luca Carmisciano, Alessio Signori, et al.The Lancet. Neurology|June 8, 2013
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trialsMaria Pia Sormani, Paolo BruzziMultiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2016
Reporting treatment outcomes in observational data: A fine balanceTomas Kalincik, Maria Pia SormaniMultiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
Estimating a treatment effect: Choosing between relative and absolute measuresMaria Pia Sormani, Paolo BruzziJournal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 12, 2007
Statistical issues related to the use of MRI data in multiple sclerosisMaria Pia Sormani, Massimo FilippiNature Reviews. Neurology|December 24, 2014
Can we measure long-term treatment effects in multiple sclerosis?Maria Pia Sormani, Paolo BruzziNature Reviews. Neurology|July 31, 2013
Defining and scoring response to IFN-β in multiple sclerosisMaria Pia Sormani, Nicola De StefanoBrain Communications|January 8, 2025
A data-driven model of disability progression in progressive multiple sclerosisSara Garbarino, Carmen Tur, Marco Lorenzi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 18, 2022
Is the effect of drugs in progressive MS only due to an effect on inflammation? A subgroup meta-analysis of randomised trialsMirko Capanna, Alessio Signori, Maria Pia SormaniMultiple Sclerosis and Related Disorders|August 2, 2025
Real-world experience with cladribine in the two years since treatment start: A systematic review and meta-analysisAngela Albanese, Irene Schiavetti, Maria Pia SormaniPageof 87